Live attenuated vaccine formulation targeting varicella-zoster virus reactivation, supplied by pharmaceutical manufacturers to distributors and healthcare providers. Utilized in adult immunization programs by hospitals, clinics, and public health agencies for procurement in geriatric care facilities.